We analyzed mammary carcinogenesis, angiogenesis and therapeutic responses in F1 hybrid mice expressing both human full-length HER2 and Delta16 isoforms, to model isoform interactions at work in human breast cancer. Here, ERBB2 is linked to breast carcinoma.